Search Results for: Month

July 12, 2022July 12, 2022

In Recent Decades, Immunotherapy Extended Advanced Melanoma Survival from Months to Years

Melanoma News

Publication date: Jul 12, 2022 So between 2011 and 2021, we’ve seen the median life expectancy of someone (with) metastatic melanoma go from seven months to just over six years. ... Read more

August 15, 2022August 15, 2022

Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases.

Parkinson's Disease Literature

Publication date: Aug 12, 2022 Isolated rapid eye movement sleep behavior disorder (IRBD) is a well-established clinical risk factor for Lewy body diseases (LBDs), such as Parkinson’s disease (PD) and ... Read more

August 15, 2022August 15, 2022

Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases.

Parkinson's Disease Literature

August 13, 2022August 14, 2022

Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China.

Melanoma Literature

Publication date: Aug 12, 2022 Anti-melanoma differentiation-associated gene 5 positive (anti-MDA5+) dermatomyositis (DM) has a close relationship with rapidly progressive interstitial lung disease (RPILD) and is associated with high mortality. ... Read more

August 13, 2022August 13, 2022

Prevalence and Risk Factors of Depression between Patients with Parkinson’s Disease and Their Caregivers: A One-Year Prospective Study.

Parkinson's Disease Literature

Publication date: Jul 14, 2022 Depression is a common comorbidity in patients with Parkinson’s disease (PD) and in their caregivers. This study aimed to compare the prevalence and risk factors ... Read more

August 13, 2022August 13, 2022

A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma.

Melanoma Literature

Publication date: Aug 01, 2022 Talimogene laherparepvec (T-VEC) is approved for the treatment of unresectable melanoma in the USA, Europe, and Australia. This phase I, multicenter, open-label, dose de-escalation study ... Read more

August 13, 2022August 13, 2022

The Impact of SARS-CoV-2 Pandemic on Patients with Malignant Melanoma at a Romanian Academic Center: A Four-Year Retrospective Analysis.

Melanoma Literature

Publication date: Jul 12, 2022 Considering cancer patients may be at an increased risk of severe COVID-19 disease, their oncologic treatment cannot be delayed without risking their oncologic outcomes. Considering ... Read more

August 12, 2022August 12, 2022

Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors.

Melanoma Literature

Publication date: Aug 09, 2022 Immune checkpoint inhibitors (ICIs) have started a new era in treating patients with cancer. The effect of comorbidities and concomitant drug use on ICIs have ... Read more

August 12, 2022August 12, 2022

Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors.

Melanoma Literature

August 12, 2022August 12, 2022

Effect of Prior Diagnoses on Dermatopathologists’ Interpretations of Melanocytic Lesions: A Randomized Controlled Trial.

Melanoma Literature

Publication date: Aug 10, 2022 Medical second opinions are common, although little is known about the best processes for obtaining them. This study assesses whether knowledge of a prior physician’s ... Read more